Astech Projects Launch REACTS™: Rapid, Effective and Complete Technical Support
News Mar 28, 2008
Astech Projects has announced the launch of its new automation maintenance service - REACTS™: Rapid, Effective and Complete Technical Support.
Astech says that, combining its automation experience and extensive engineering expertise, REACTS is an extension of the high quality customer service for which Astech is well known.
In addition to existing Astech automation specialists, the company has recruited four respected engineers with many years’ experience working with top 10 pharma companies worldwide.
The new REACTS team will provide automation installation and maintenance services, and technical support for any automation system in the drug discovery and pharmaceutical manufacturing sectors throughout Europe, North America and Asia.
Astech Projects’ Sales & Marketing Director, Anthony Moran, commented, “REACTS has really evolved from a service that we are already providing our customers. Now with a larger, dedicated team that is solely devoted to this service we can provide support on a truly global scale for the all existing automation, including third party systems.”
He continued, “Our new team has an excellent background and brings with it in-depth industry knowledge. This is an essential requirement for our REACTS service and their expertise compliments our highly proficient team of mechanical, electrical, control and software engineers.”
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
Synthesis of Drug-Like Molecules Simplified Using New Cross-Coupling MethodNews
Researchers have designed a new molecule-building method. The technique, described recently in the journal Science, paves the way toward other new chemical reactions and facilitates the synthesis of pharmaceutically-relevant molecules.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE